Free-feeding animals often face complex nutritional choices that require the balancing of competing nutrients, yet the mechanisms driving macronutrient specific food intake are poorly defined. A large number of behavioral studies indicate that both the quantity and quality of dietary protein can markedly influence food intake and metabolism, and that dietary protein intake may be prioritized over energy intake. This review focuses on recent progress in defining the mechanisms underlying protein-specific feeding. Considering the evidence that protein powerfully regulates both food intake and metabolism, uncovering these protein specific mechanisms may reveal new molecular targets for the treatment of obesity and diabetes while also offering a more complete understanding of how dietary factors shape both food intake and food choice.
progress in defining a neuroendocrine mechanism governing 'protein homeostasis', despite a large and compelling literature indicating that variations in dietary protein or amino acid content produce profound changes in feeding behavior and metabolic health [1] .
Behavioral responses to dietary protein
The experimental manipulation of dietary protein substantially alters feeding behavior, metabolism and growth. Studies focusing on the impact of dietary protein on feeding behavior have led to three general conclusions: 1) Diets with severe amino acid imbalance or that are devoid of a single essential amino acid reduce food intake and produce a learned avoidance of the imbalanced diet, 2) High protein (HP) diets tend to suppress food intake acutely, and promote reductions in fat mass but maintenance of lean mass chronically, and 3) Moderately low protein (LP) diets increase food intake and protein selection, while extremely LP diets can reduce food intake. A brief overview of these behavioral responses is provided for perspective, and the reader is referred to several recent reviews which cover this field in more depth [1] [2] [3] [4] [5] [6] .
Effects of HP and LP diets
HP diets suppress food intake over the short term, with protein being the most satiating macronutrient per calorie [3, 4, 7] . A large number of clinical studies indicate that HP diets promote weight and adiposity loss by reducing food intake, maintaining fat free mass and increasing energy expenditure [8] . For these reasons the maintenance of protein intake but reduction of energy intake is a central focus of many weight loss strategies [4, 9] . Similar data exist in rodents, although some studies describe a waning of the anorectic effect over time due to adaptive increases in amino acid metabolism [10] [11] [12] [13] .
Fewer studies have focused on the response to a LP diet, and the effect seems to be dependent on the degree of protein restriction and the physiological state of the animal. Rats and mice exhibit hyperphagia in response to moderately LP diets [14] [15] [16] , but will abandon this approach and spontaneously reduce food intake if the protein content is extremely low [17] . Recent studies have focused on this same question in humans. Interestingly, several studies indicate that moderate restriction of protein triggers adaptive changes in food intake and preference [18] [19] [20] , whereas other studies involving more severe protein restriction have shown no effect on food intake [4, 21] .
Protein selection and amino acid imbalance
There exists a large body of data indicating that a wide range of species will self-select between diets that are high and low in protein to meet protein requirements [1] . Although there is debate as to whether this self-selection produces a precise regulation of protein intake, work utilizing the Geometric Framework to model the interacting effects of all three macronutrients strongly suggests that species as diverse as fish, insects, rodents and pigs seek to consume a specific protein:carbohydrate target, and will prioritize protein over energy [22, 23] . The ability to select for protein also appears to be sensitive to physiological status, as protein selection increases in response to periods of increased protein demand, such as during periods of rapid growth [23, 24] .
Evidence also supports selection based on the composition of individual amino acids, not just total protein. Rats rapidly detect and readily avoid diets that are deficient in a single essential amino acid [6] , will specifically select the missing amino acid over other nonrestricted amino acids in a choice test, and appear to be able to distinguish between minute changes in dietary amino acid content [25, 26] . While diets that are completely devoid of a single amino acid induce aversion and are incompatible with life, a more moderate restriction of a single amino acid increases food intake and actually extends lifespan. The most compelling evidence for this effect comes from work focusing on methionine restriction, which increases food intake and energy expenditure, improves lipid metabolism and insulin sensitivity, and increases lifespan [27] [28] [29] [30] . These data suggest that moderate restriction of a single amino acid produces a different physiological response compared to the complete deprivation of that amino acid.
While dietary protein clearly exerts a profound effect on feeding behavior, metabolism and growth, at issue is whether these effects represent a specific, physiologic regulation of protein intake (i.e. protein homeostasis). While the evidence suggests that protein and energy are independently balanced, we currently have a poor understanding of the mechanisms that might contribute to such a protein-specific response. Below we discuss the potential mechanisms underlying protein-dependent regulation of food intake and metabolism.
Potential mechanisms underlying protein intake and selection
As with any nutrient, the identification, consumption, digestion, absorption and utilization of amino acids is a complex process. Information regarding dietary protein intake or protein status could be transmitted to the brain in a large number of ways, including via taste (umami), neural or endocrine signals from the gastrointestinal (GI) tract, hormones generated by liver or skeletal muscle based on amino acid availability or metabolism, or finally a direct brain effect of circulating amino acids. Delineating the role of these individual pathways is a daunting task, and indeed it seems likely that multiple signals participate in this process. Three mechanisms have been most predominately linked to the response to dietary protein: 1) Direct effects of amino acids in the brain, 2) Gut-derived neural or hormonal signals, and 3) Other endocrine signals, namely fibroblast growth factor 21 (FGF21). We discuss their contribution to the organism's response to amino acid imbalance, HP and LP diets (Figure 1 ).
Direct effects of amino acids on the brain
As mentioned above, diets that are completely devoid of a single amino acid reduce food intake and induce a learned aversion. There is very strong evidence to suggest that the detection of this imbalance is mediated by the depletion of the limiting amino acid and the resulting activation of the serine/threonine kinase general control nonderepressible-2 (GCN2) within the brain anterior piriform cortex (APC) [6, [31] [32] [33] . GCN2 is a conserved amino acid sensor that couples amino acid availability to protein synthesis [34] [35] [36] , and therefore its activation in the APC provides a molecular mechanism for brain detection of amino acid restriction. However, to date this APC-centric mechanism has not been connected to the regulation of food or protein intake in other settings, although GCN2 has been linked to the metabolic effects of single amino acid deficiency on the liver [36] [37] [38] [39] . Whether GCN2 similarly contributes to more moderate restriction of single amino acids or general dietary protein restriction remains unclear, but this distinction is important considering the divergent feeding response to complete deficiency (hypophagia) vs. modest restriction (hyperphagia). Finally, a separate brain signaling system has been implicated in the response to a leucine-devoid diet, although in this case the primary endpoint is the induction of energy expenditure. These studies suggest that leucine deprivation influences ribosomal protein S6 kinase beta-1 (S6K1) signaling and regulates neurons expressing melanocortin receptor (MCR4), corticotropin-releasing hormone (CRH) and thyrotropinreleasing hormone (TRH) in the hypothalamus, leading to an activation of the sympathetic nervous system and increased energy expenditure [40, 41] Currently it is not completely clear whether these effects are mediated by direct amino acid detection within the hypothalamus or instead via a separate organ that relays a signal to the central nervous system (CNS).
In addition to the detection of amino acid imbalance, there is also evidence that the anorexia of HP diets may be driven by the branched-chain amino acid (BCAA) leucine acting locally in the hypothalamus and brainstem [42] . Direct injection of leucine into the brain is sufficient to suppress food intake [43] , and leucine can act locally within the mediobasal hypothalamus [44] , via activation of mammalian target of rapamycin (mTOR) and/or inhibition of AMP-activated protein kinase (AMPK) signaling [15, 43, 45] , or via activation of BCAA metabolism [44] . Leucine can also act locally within the brainstem to suppress food intake, via local induction of both mTOR and ERK signaling [46] . Finally, the anorectic effect of intracerebroventricular leucine injection is not common to other amino acids [47] , suggesting that leucine uniquely acts as a signaling molecule in the brain. It should be noted, however, that nearly all of these experiments involve the direct injection of leucine into the CNS, and as such it is less clear whether fluctuations in brain leucine are connected to diet-induced changes in food intake. In support of leucine's physiological role, several studies suggest that supplementing diets with leucine or BCAAs is sufficient to reproduce the anorectic effects of HP diets [45, 48] . However, in other studies leucine fails to suppress food intake after being administered via the drinking water, gavage, gastric infusion, or intraperitoneal injection [49] [50] [51] [52] . Finally, there is also evidence that other amino acids act on the brain, as it was shown that the anorectic effects of both intragastrically or intravenously administered arginine and glutamate required the area postrema [52] . These results collectively indicate that amino acids can alter food intake via direct effects in the brain and support GCN2, mTOR and AMPK as molecular mediators of this effect. However, these data also highlight the need for additional work delineating whether individual amino acids act in functionally unique ways as well as whether combinations of amino acids act in concert to induce effects that are not reproduced by any single amino acid.
While the brain appears to directly sense both amino acid imbalance and amino acid excess, the evidence is weaker regarding whether reductions in brain amino acids contribute to the hyperphagia observed in response to dietary protein restriction. Blood amino acids are buffered by metabolic adaptations that occur within liver and skeletal muscle during protein restriction, and thus LP diets tend to produce only modest, transient reductions in circulating amino acids [47, 53] . It was recently demonstrated that reduced dietary leucine or BCAA content was neither necessary nor sufficient to trigger hyperphagia in rats consuming a LP diet, and that chronic infusion of amino acids into the brain failed to block this LP-induced hyperphagia [47] . These observations are consistent with earlier work demonstrating that elevating BCAA content in a low protein diet had no effect on consumption of that diet in a self-selection paradigm [54] , and collectively suggest that reductions in BCAAs alone are insufficient to trigger hyperphagia on a LP diet.
Detection of amino acids in the GI tract and portal system: Protein-induced satiety HP preloads induce a robust suppression of food intake that is greater than isocaloric loads of either carbohydrate or fat. There is strong support for the hypothesis that this proteininduced satiety is mediated via actions within the GI tract or portal circulation, which are then transmitted to the brain via neural (vagal, spinal) or endocrine (gut peptide) signals [55] . HP meals lead to enhanced activation of the vagus nerve and hindbrain [56] and induce a pattern of hindbrain c-Fos activation that is distinct from that observed with sucrose loads [57] . HP diet also promotes larger increases in glucagon-like peptide-1 (GLP1), peptide YY (PYY), cholecystokinin (CCK) and glucagon levels, and greater reductions in ghrelin levels [58] [59] [60] , while PYY deficient mice are resistant to HP-induced decreases in food intake and body weight [61] . An additional mechanism to explain the anorectic effects of dietary protein is the induction of intestinal gluconeogenesis and its detection via a portal vein glucose sensor [62] . The functional relevance of this portal mechanism was demonstrated by the fact that denervation of the portal vein blocked the anorexia induced by portal vein glucose infusion [63] , while inhibition of intestinal gluconeogenesis blocked the anorexia induced by a HP diet [64] .
While the evidence strongly supports the hypothesis that gut-derived signals decrease the consumption of high protein diets, whether these same signals increase the consumption of low protein diets has received much less scrutiny. It is known that the effect of dietary protein on gut hormone secretion is dose dependent, such that LP diets lead to smaller changes in CCK or ghrelin levels relative to control diets [58, 65] . Thus a muted regulation of gut hormone secretion may contribute to LP-induced hyperphagia, although no interventional studies have been conducted to provide compelling support for this hypothesis. Finally, it should also be noted that protein restriction also triggers increased selection for protein [18, 20, 66, 67] and this selection for protein is also apparent in physiological settings of increased protein demand, such as during rapid growth [24] . In other words, regulatory mechanisms detect negative protein balance induced either by reductions in protein intake or increases in protein demand. Currently the neuroendocrine mechanisms underlying this response are completely unclear, as there is no compelling evidence than any of these gut hormones influence macronutrient selection [2] and it is problematic to hypothesize that the gut is a sensor of systemic protein balance. Thus while gut-derived signals are clearly influenced by dietary protein content and contribute to the satiety induced by high protein diets, whether these hormones contribute to the detection of negative protein balance is much less clear.
Homeostatic endocrine signals: FGF21 as a signal of protein restriction
When considering how protein balance might be regulated, it is perhaps worthwhile to consider the mechanisms governing energy balance. While it is well accepted that both glucose and lipids act directly in the brain and that food intake is influenced by gut-derived vagal and endocrine signals, there is consensus that the long-term regulation of energy balance is primarily mediated by hormones such as leptin, an adipose tissue-derived hormone that serves as a signal of the amount of fat (energy) stored in the body. In fact, leptin regulates energy homeostasis in part by interacting with these more short term satiety cues while also coordinating adaptive changes in growth, reproduction, energy expenditure and glucose homeostasis. Just as leptin is a signal of energy status, are there endocrine hormones which are uniquely regulated by protein status and which coordinate behavior and metabolism in response to altered protein intake? Considering that both skeletal muscle and liver represent key sites of amino acid metabolism and protein synthesis, these two organs represent logical sites to look for such a protein specific signal. Skeletal muscle produces a large number of endocrine hormones, many of which can gain access to the CNS [68] . However, to date there has been little progress in identifying a muscle-derived signal that communicates to the brain to regulate food intake, and almost no work has focused on such a signal in the context of altered protein status.
The liver is particularly well suited to act as a sensor of dietary protein intake. The liver is critical for amino acid catabolism and biosynthesis, and protein/amino acid restriction induces significant changes in hepatic metabolism and gene expression [53, 69] . Importantly, very recent research has identified a novel endocrine pathway for the detection of dietary amino acid or protein restriction, with this mechanism centering on FGF21. Initial studies demonstrated that FGF21 is induced by starvation and ketogenic diets [70] [71] [72] , and that increases in FGF21 influence glucose and lipid metabolism while also increasing energy expenditure, brown adipose tissue activity and the browning of white fat [73] [74] [75] [76] [77] [78] . FGF21 appears to induce these metabolic effects by acting in a variety of sites, most notably adipose tissue [79, 80] and brain [81] [82] [83] .
A connection between FGF21 and protein intake was established when it was shown that hepatic FGF21 expression is induced in vitro and in vivo by the depletion of single amino acids (leucine, histidine or asparagine) via a mechanism involving GCN2-dependent phosphorylation of eukaryotic initiation factor 2α (eIF2α) and activation of activating transcription factor 4 (ATF4) [38, [84] [85] [86] [87] . Work focusing on models of dietary methionine restriction indicates that methionine restriction-induced increases in FGF21 are essential for the beneficial metabolic effects seen in the absence of the amino acid [28, 29] . Finally, the role of FGF21 in the behavioral and metabolic responses to general dietary protein restriction was tested recently [14] . These data indicate that dietary protein restriction triggers a rapid and robust increase in circulating FGF21 in rodents and humans, that this effect is not replicated by the restriction of energy alone, and that the increases in food intake and energy expenditure during dietary protein restriction are completely lost in FGF21-deficient mice [14] . These data therefore suggest that FGF21 may be the first known endocrine hormone specifically activated by the restriction of protein or amino acids. Additional work is clearly required to place this new observation within the larger context of FGF21 biology, but it is provocative to hypothesize an important interaction between the protein signal FGF21 and energy signals such as leptin and insulin [88] [89] [90] . Taken together, these data identify FGF21 as a key player in a fundamentally new mechanism through which feeding behavior, growth and metabolism are coordinated during periods of reduced dietary protein intake.
Concluding remarks and future perspectives
The consumption of essential amino acids is required for health and survival, and as such it should not be surprising that physiological mechanisms exist to match protein intake to physiological protein demand. Behavioral studies clearly indicate that variations in protein quantity and quality induce marked changes in feeding behavior and metabolism, and substantial progress has been made in identifying potential mechanisms underlying these effects. It is now well established that the learned avoidance of severely imbalanced diets is mediated by activation of GCN2 signaling within the brain APC, that amino acids (particularly leucine) can suppress food intake by acting locally within the hypothalamus and brainstem to regulate mTOR and AMPK signaling, and that high protein diets induce satiety via a robust stimulation of gut hormone and vagal satiety signaling. Finally, recent data implicate the metabolic hormone FGF21 as a critical mediator of adaptive changes in food intake and metabolism during the restriction of individual amino acids or total dietary protein.
Yet despite this progress, substantial questions still remain. Perhaps the most critical is the fact that CNS control of macronutrient selection remains virtually undescribed. We currently have little insight into how the brain specifically regulates protein intake, and how protein intake is balanced against other macronutrients and total energy. Currently no brain area or neuronal population has been compellingly linked to a specific selection for protein, and even though FGF21 appears to be an endocrine signal of protein restriction, it remains unclear if coordinating the physiological response to protein restriction is the primary biological role of FGF21. Finally, it should also be recognized that protein is rarely consumed in isolation, and that the ratio of protein to carbohydrate and fat may be equally as important to physiology as the absolute amount of protein [91] .
Recent decades have seen a substantial expansion of our understanding of the neurobiology of feeding behavior, with this work principally focusing on the concept of energy balance. This review argues that food intake may be governed by more than just the consumption of energy, and has specifically emphasized protein as a separately detected nutritional variable. Just as nutritional cues impinge on the brain to coordinate adaptive responses to energy imbalance, additional cues may also coordinate adaptive responses to protein imbalance. Dietary protein exerts a powerful effect on food intake and has been strongly linked to metabolic health and longevity [91, 92] . As such, uncovering and tapping into this mechanism has the potential to produce novel approaches for the treatment of obesity and metabolic disease.
Glossary

Activating transcription factor 4 (ATF4)
A transcription factor that induces the expression of stress response genes as part of the integrated stress response. ATF4 is downstream of GCN2/eIF2α and is activated by amino acid restriction.
AMP-activated protein kinase (AMPK)
A kinase that is activated by cellular energy restriction that functions as a metabolic switch to coordinate diverse cellular responses to nutrient restriction.
Anterior piriform cortex (APC)
An area of the cortical brain classically associated with olfaction, but which is essential for the anorexia induced by deprivation of a single essential amino acid.
Cholecystokinin (CCK)
A gut derived hormone that reduces food intake in response to food ingestion.
Corticotropin-releasing hormone (CRH)
A neuropeptide, mainly produced in the hypothalamus, associated with the response to various stressors.
Eukaryotic initiation factor 2α (eIF2α)
A cellular protein that is phosphorylated by a variety of upstream kinases in response to cellular stress, including GCN2. eIF2α phosphorylation leads to the inhibition of cellular protein synthesis but the specific activation of the integrated stress response.
Extracellular signalregulated kinase (ERK)
A kinase that serves as a primary intracellular signaling molecule mediating the cellular response to a variety of growth factors.
Fibroblast growth factor 21 (FGF21)
A nutritionally regulated hormone which induces a broad range of beneficial metabolic effects.
General control nonderepressible 2 (GCN2)
A serine/threonine kinase that is activated by essential amino acid restriction and phosphorylates eIF2α to inhibit cellular protein translation and induce a series of cellular stress responses.
Geometric Framework
A state-space modeling method that has been used to model the interacting effects of macronutrient intake on physiological endpoints.
Glucagon-like peptide-1 (GLP1)
Mammalian target of rapamycin (mTOR)
a kinase that coordinates diverse cellular responses to variations in nutrient availability and growth factor signaling.
Melanocortin-4 receptor (MCR4)
Receptor expressed on neurons within the brain associated with regulation of body weight, food intake and energy expenditure.
Peptide YY (PYY)
Thyrotropin-releasing hormone (TRH)
A neuropeptide associated with the regulation of thyroid hormone, but which also acts on diverse neural systems.
Ribosomal protein S6 kinase beta-1 (S6K1)
A kinase which phosphorylates ribosomal protein S6 in response to upstream activation by mTOR, coordinating the effect of growth factors and nutrients on cell growth. Dietary protein within the GI tract activates both endocrine and vagal signals, which act in a primarily anorexigenic fashion in the hypothalamus and brainstem. Absorbed amino acids are delivered to the liver via the hepatic portal vein. Reduced amino acid supply to the liver increases hepatic FGF21 secretion, which acts in the brain to increase both food intake and energy expenditure, likely via effects in the hypothalamus. Amino acids are transported out of the liver and into the general circulation, and circulating amino acids can act in both the hypothalamus and brainstem to suppress food intake. Finally, imbalances in dietary or circulating amino acid concentrations are detected in the anterior piriform cortex (APC), with activation of the APC reducing food intake. These various mechanisms allow animals to detect and adaptively respond to diets that are high, low or imbalanced in amino acid content.
